English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [658]
News [1456]
Articles [246]
Editorials [9]
Conferences [82]
elearning [17]
ASCO 2020: Maintenance therapy With PARP inhibitor olaparib extends survival by over 1 year in patients with relapsed ovarian cancer and BRCA mutation
ASCO 2020: Maintenance therapy With PARP inhibitor olaparib extends survival by over 1 year in patients with...
Cervical cancer screening during the COVID-19 Crisis: Africa view point
Cervical cancer screening during the COVID-19 Crisis: Africa view point
FDA approves olaparib plus bevacizumab as maintenance treatment for ovarian, fallopian tube, or primary peritoneal cancers
FDA approves olaparib plus bevacizumab as maintenance treatment for ovarian, fallopian tube, or primary peritoneal...
Gynaecological cancers in the era of fertility preservation - A new special issue from ecancer
Gynaecological cancers in the era of fertility preservation - A new special issue from ecancer
FDA approves niraparib for first-line maintenance of advanced ovarian cancer
FDA approves niraparib for first-line maintenance of advanced ovarian cancer
AACR 2020: Study of nearly 10,000 women explores feasibility and safety of multi-cancer blood test
AACR 2020: Study of nearly 10,000 women explores feasibility and safety of multi-cancer blood test
AACR 2020: New therapy with potential benefit for underserved patients with lung and ovarian cancers
AACR 2020: New therapy with potential benefit for underserved patients with lung and ovarian cancers
New targeted agent produces considerable responses in patients with uterine cancer
New targeted agent produces considerable responses in patients with uterine cancer
Gene signature found for poor response to standard chemotherapy in rare uterine cancer
Gene signature found for poor response to standard chemotherapy in rare uterine cancer
Human uterus colonised by clones with cancer-driving mutations that arise early in life
Human uterus colonised by clones with cancer-driving mutations that arise early in life
<1...5455565758...146>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top